7-116782048-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_000245.4(MET):c.3583C>T(p.Leu1195Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1195V) has been classified as Pathogenic.
Frequency
Consequence
NM_000245.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MET | NM_000245.4 | c.3583C>T | p.Leu1195Phe | missense_variant | Exon 18 of 21 | ENST00000397752.8 | NP_000236.2 | |
MET | NM_001127500.3 | c.3637C>T | p.Leu1213Phe | missense_variant | Exon 18 of 21 | NP_001120972.1 | ||
MET | NM_001324402.2 | c.2293C>T | p.Leu765Phe | missense_variant | Exon 17 of 20 | NP_001311331.1 | ||
MET | XM_011516223.2 | c.3640C>T | p.Leu1214Phe | missense_variant | Exon 19 of 22 | XP_011514525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MET | ENST00000397752.8 | c.3583C>T | p.Leu1195Phe | missense_variant | Exon 18 of 21 | 1 | NM_000245.4 | ENSP00000380860.3 | ||
MET | ENST00000318493.11 | c.3637C>T | p.Leu1213Phe | missense_variant | Exon 18 of 21 | 1 | ENSP00000317272.6 | |||
MET | ENST00000436117.3 | n.*1188C>T | non_coding_transcript_exon_variant | Exon 17 of 20 | 1 | ENSP00000410980.2 | ||||
MET | ENST00000436117.3 | n.*1188C>T | 3_prime_UTR_variant | Exon 17 of 20 | 1 | ENSP00000410980.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Renal cell carcinoma Uncertain:1
This sequence change replaces leucine with phenylalanine at codon 1213 of the MET protein (p.Leu1213Phe). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and phenylalanine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MET-related conditions. ClinVar contains an entry for this variant (Variation ID: 246643). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.L1213F variant (also known as c.3637C>T), located in coding exon 17 of the MET gene, results from a C to T substitution at nucleotide position 3637. The leucine at codon 1213 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at